Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
roberta.costi@uniroma1.it
Roberta Costi
Professore Associato
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
roberta.costi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site
MOLECULES
2023
Pyrrolyl and indolyl α-γ-diketo acid derivatives acting as selective inhibitors of human carbonic anhydrases IX and XII
PHARMACEUTICALS
2023
Plants and Small Molecules: An Up-and-Coming Synergy
PLANTS
2023
Oxidative stress and visual system a review
EXCLI JOURNAL
2022
The kinesin Eg5 inhibitor K858 exerts antiproliferative and proapoptotic effects and attenuates the invasive potential of head and neck squamous carcinoma cells
INVESTIGATIONAL NEW DRUGS
2022
Synthesis and evaluation of the antifungal and toxicological activity of Nitrofuran derivatives
PHARMACEUTICS
2022
Evaluation of the Anti-Histoplasma capsulatum activity of Indole and Nitrofuran derivatives and their pharmacological safety in three-dimensional cell cultures
PHARMACEUTICS
2022
Design, synthesis, and In vitro, in silico and in cellulo evaluation of new Pyrimidine and Pyridine amide and Carbamate derivatives as multi-functional Cholinesterase Inhibitors
PHARMACEUTICALS
2022
Exosomal Functional Cargoes from Liquid Biopsy of Gastric Cancer: A Systematic Review of Studies With Potential Clinical Relevance
ANTICANCER RESEARCH
2022
Ultrastructural damages to H1N1 influenza virus caused by vapor essential oils
MOLECULES
2022
New Inhibitors of the Human p300/CBP Acetyltransferase Are Selectively Active against the Arabidopsis HAC Proteins
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Exosomal Functional Cargoes from Liquid Biopsy of Gastric Cancer: A Systematic Review of Studies With Potential Clinical Relevance
ANTICANCER RESEARCH
2022
Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease–a patent review (2016–present)
EXPERT OPINION ON THERAPEUTIC PATENTS
2021
Design, synthesis and biological evaluation of new pyrimidine derivatives as anticancer agents
MOLECULES
2021
Investigation of Commiphora myrrha (Nees) Engl. Oil and Its Main Components for Antiviral Activity
PHARMACEUTICALS
2021
Analytical characterization of an inulin-type fructooligosaccharide from root-tubers of Asphodelus ramosus L
PHARMACEUTICALS
2021
Design, synthesis and biological evaluation of a series of iron and copper chelating deferiprone derivatives as new agents active against Candida albicans
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
2021
Anti-tumoral effects of a (1H-pyrrol-1-yl)methyl-1H-benzoimidazole carbamate ester derivative on head and neck squamous carcinoma cell lines
PHARMACEUTICALS
2021
Effect of Heparanase inhibitor on Tissue Factor overexpression in platelets and endothelial cells induced by anti-β2-GPI antibodies
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
2021
Quinolinonyl non-diketo acid derivatives as Inhibitors of HIV-1 ribonuclease H and polymerase functions of reverse transcriptase
JOURNAL OF MEDICINAL CHEMISTRY
2021
1
2
3
seguente ›
ultima »
Progetti di Ricerca
Development of Inhibitors Targeting CoronaViruses-related diseases
Design and Development of novel Heparanase inhibitors able to modulate autophagy
Novel selective inhibitors of ribonuclease H function of the HIV-1 reverse transcriptase enzyme
Innovative small molecules as inhibitors of ribonuclease H function of the HIV-1 reverse transcriptase enzyme
Targeting poverty-related co-infectious diseases through drug lead optimization and combination studies
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma